Approvals & regulatory · first seen yesterday, updated yesterday

FDA Warns Pharmacy About Illegal GLP-1 Compounding

1 outlet GLP-1 & obesity drugs FDA

(MedPage Today) -- The FDA issued a warning letter this month to Empower Pharmacy over its mass production of compounded GLP-1 weight-loss and diabetes drugs, citing illegal copycat manufacturing and insanitary conditions. Following a facil…

Summary from MedPage Today.

Coverage 1 article · 1 outlet

MedPage Today yesterday
FDA Warns Pharmacy About Illegal GLP-1 Compounding